Obesity Reviews最新文献

筛选
英文 中文
Metabolomics: Implication in cardiovascular research and diseases 代谢组学:对心血管研究和疾病的影响。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-10-06 DOI: 10.1111/obr.13825
Amir Ajoolabady, Domenico Pratico, Warwick B. Dunn, Gregory Y. H. Lip, Jun Ren
{"title":"Metabolomics: Implication in cardiovascular research and diseases","authors":"Amir Ajoolabady,&nbsp;Domenico Pratico,&nbsp;Warwick B. Dunn,&nbsp;Gregory Y. H. Lip,&nbsp;Jun Ren","doi":"10.1111/obr.13825","DOIUrl":"10.1111/obr.13825","url":null,"abstract":"<div>\u0000 \u0000 <p>Cellular metabolism influences all aspects of cellular function and is crucial for overall organismal health. Metabolic disorders related to cardiovascular health can lead to cardiovascular diseases (CVDs). Moreover, associated comorbidities may also damage cardiovascular metabolism, exacerbating CVD and perpetuating a vicious cycle. Given the prominent role of metabolic alterations in CVD, metabolomics has emerged as an imperative technique enabling a comprehensive assessment of metabolites and metabolic architecture within the body. Metabolite profile and metabolic pathways help to deepen and broaden our understanding of complex genomic landscape and pathophysiology of CVD. Here in this review, we aim to overview the experimental and clinical applications of metabolomics in pathogenesis, diagnosis, prognosis, and management of various CVD plus future perspectives and limitations.</p>\u0000 <p></p>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"25 12","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142379588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review 超重和肥胖症患者饮食失调症发病和发展的潜在途径:范围综述。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-10-04 DOI: 10.1111/obr.13840
Rabia Khalid, Natalie B. Lister, Susan J. Paxton, Sarah Maguire, Sol Libesman, Anna L. Seidler, Kelly Cooper, Fiona Quigley, Jacqlyn Yourell, Louise A. Baur, Hiba Jebeile
{"title":"Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review","authors":"Rabia Khalid,&nbsp;Natalie B. Lister,&nbsp;Susan J. Paxton,&nbsp;Sarah Maguire,&nbsp;Sol Libesman,&nbsp;Anna L. Seidler,&nbsp;Kelly Cooper,&nbsp;Fiona Quigley,&nbsp;Jacqlyn Yourell,&nbsp;Louise A. Baur,&nbsp;Hiba Jebeile","doi":"10.1111/obr.13840","DOIUrl":"10.1111/obr.13840","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To describe pathways to eating disorder (ED) development that have been evaluated in people with overweight and obesity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Four databases were searched to identify studies testing ED development models in adolescents (10–19 years) or adults (&gt;19 years) with overweight and obesity. Explanatory variables were thematically grouped into constructs to describe pathways to each ED outcome.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 2226 studies screened, 46 (10 adolescent; 36 adult) were included. Study samples were predominantly female, ranging from 22 to 2236 participants and mean age 12.3 to 56.0 years. In total, 207 explanatory variables were grouped into 18 constructs to summarize 107 pathways that were identified. The most common ED outcome was binge eating (<i>n</i> = 24 studies), followed by global ED psychopathology (<i>n</i> = 10 studies). Across pathways to ED development, negative affect was the most proposed construct, followed by preoccupation with weight/shape and weight stigma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Pathways to ED development in people with overweight and obesity are complex and may include more than 18 different explanatory factors of which negative affect, preoccupation with weight/shape, and weight stigma are the most common. More research on adolescents, males, and the spectrum of ED in diverse populations is required for early identification and intervention.</p>\u0000 </section>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13840","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142374769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating discrepancies in findings between rigorous randomized trials and meta-analyses evaluating pregnancy interventions to limit gestational weight gain 调查评估限制妊娠体重增加的孕期干预措施的严格随机试验和荟萃分析结果之间的差异。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-10-03 DOI: 10.1111/obr.13826
Jodie M. Dodd, Andrea R. Deussen, Amanda J. Poprzeczny, Laura J. Slade, Megan Mitchell, Jennie Louise
{"title":"Investigating discrepancies in findings between rigorous randomized trials and meta-analyses evaluating pregnancy interventions to limit gestational weight gain","authors":"Jodie M. Dodd,&nbsp;Andrea R. Deussen,&nbsp;Amanda J. Poprzeczny,&nbsp;Laura J. Slade,&nbsp;Megan Mitchell,&nbsp;Jennie Louise","doi":"10.1111/obr.13826","DOIUrl":"10.1111/obr.13826","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Robust randomized trials consistently demonstrate little impact from diet and physical activity interventions on gestational weight gain (GWG) and clinical outcomes, although meta-analyses report some benefit. Our aim was to evaluate the effect of trial quality on treatment effect estimates and review conclusions.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a systematic review of dietary and/or physical activity interventions for pregnant women with a body mass index ≥18.5 kg/m<sup>2</sup>. We assessed studies for risk of bias and methodological features impacting reliability. Outcomes included GWG; gestational diabetes mellitus (GDM); pre-eclampsia; caesarean birth; and birth weight measures. For each outcome, a sequence of meta-analyses was performed based on intervention group and level of potential bias in the effect estimate.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>We identified 128 eligible studies. The most robust estimate from a combined diet and physical activity behavioral intervention, with only studies at negligible risk of bias, was a difference in GWG of 1.10 kg (95% CI −1.62 to −0.58; 17,755 women). There was no evidence of an effect on any clinical outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Our findings highlight discrepancies produced by the indiscriminate inclusion of studies with methodological flaws in previous systematic reviews. Regular weighing of pregnant women is futile in the absence of clinical benefit.</p>\u0000 </section>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"25 12","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13826","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142370385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and clinical application of bioelectrical impedance analysis method for body composition assessment 用于人体成分评估的生物电阻抗分析方法的开发和临床应用。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-30 DOI: 10.1111/obr.13844
Jang Won Son, Byoung-Duck Han, Jonathan P. Bennett, Steve Heymsfield, Soo Lim
{"title":"Development and clinical application of bioelectrical impedance analysis method for body composition assessment","authors":"Jang Won Son,&nbsp;Byoung-Duck Han,&nbsp;Jonathan P. Bennett,&nbsp;Steve Heymsfield,&nbsp;Soo Lim","doi":"10.1111/obr.13844","DOIUrl":"10.1111/obr.13844","url":null,"abstract":"<div>\u0000 \u0000 <p>Obesity, which is characterized by excessive body fat, increases the risk of chronic diseases, such as type 2 diabetes, cardiovascular diseases, and certain cancers. Sarcopenia, a decline in muscle mass, is also associated with many chronic disorders and is therefore a major concern in aging populations. Body composition analysis is important in the evaluation of obesity and sarcopenia because it provides information about the distribution of body fat and muscle mass. It is also useful for monitoring nutritional status, disease severity, and the effectiveness of interventions, such as exercise, diet, and drugs, and thus helps assess overall health and longevity. Computed tomography, magnetic resonance imaging, and dual-energy X-ray absorptiometry are commonly used for this purpose. However, they have limitations, such as high cost, long measurement time, and radiation exposure. Instead, bioelectrical impedance analysis (BIA), which was introduced several decades ago and has undergone significant technological advancements, can be used. It is easily accessible, affordable, and importantly, poses no radiation risk, making it suitable for use in hospitals, fitness centers, and even at home. Herein, we review the recent technological developments and clinical applications of BIA to provide an updated understanding of BIA technology and its strengths and limitations.</p>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142338005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary care practitioner and patient perspectives on care following bariatric surgery: A meta-synthesis of qualitative research 初级保健医生和患者对减肥手术后护理的看法:定性研究的元综合。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-19 DOI: 10.1111/obr.13829
Sally Badorrek, Janet Franklin, Kate A. McBride, Laura Conway, Kathryn Williams
{"title":"Primary care practitioner and patient perspectives on care following bariatric surgery: A meta-synthesis of qualitative research","authors":"Sally Badorrek,&nbsp;Janet Franklin,&nbsp;Kate A. McBride,&nbsp;Laura Conway,&nbsp;Kathryn Williams","doi":"10.1111/obr.13829","DOIUrl":"10.1111/obr.13829","url":null,"abstract":"<p>Primary care is central to ongoing health care following bariatric surgery and patients indicate a preference for receiving follow-up support by their primary care practitioner (PCP). This meta-synthesis investigates the perspectives of both PCPs and patients in post-bariatric surgery care provided by PCPs. The aim was to synthesize themes from qualitative research to recommend improvements in post-bariatric surgery clinical care in primary care settings. Systematic searches of Scopus, Medline, EMBASE, PsycINFO, the Cochrane Library, and Google Scholar resulted in the inclusion of eight papers in the meta-synthesis. Papers were critiqued using the Critical Appraisal Skills Program (CASP) and thematically coded in Quirkos Cloud. Seven themes were reached by author consensus including stigma and judgment; clinician barriers and facilitators; patient-related support needs; communication considerations; patient context or determinants; health care setting; and adapting to life after surgery. PCPs reported barriers including poor communication and guidance from bariatric surgery centers, limited knowledge and training in bariatric patient care, and patients who may have unrealistic outcomes and poor health literacy. Patients seek comprehensive care from their PCP, however, barriers hindering the provision of this care include adverse surgical outcomes, a poor relationship with their PCP, and limited and short-term follow-up care from the PCP. Insights from this meta-synthesis offer actionable recommendations for PCPs and bariatric surgery centers to enhance patient care immediately.</p>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"25 12","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13829","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of behavioral weight management interventions on eating behavior traits in children with overweight or obesity: Systematic review and meta-analysis 行为体重管理干预对超重或肥胖儿童饮食行为特征的影响:系统回顾与荟萃分析。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-19 DOI: 10.1111/obr.13839
Patricia Eustachio Colombo, Milindu Wickramarachchi, Aiswarya Lakshmi, Laura Kudlek, Amy Ahern, Struan Tait, Natasha Reid, Rebecca A. Jones, Andrea D. Smith
{"title":"The impact of behavioral weight management interventions on eating behavior traits in children with overweight or obesity: Systematic review and meta-analysis","authors":"Patricia Eustachio Colombo,&nbsp;Milindu Wickramarachchi,&nbsp;Aiswarya Lakshmi,&nbsp;Laura Kudlek,&nbsp;Amy Ahern,&nbsp;Struan Tait,&nbsp;Natasha Reid,&nbsp;Rebecca A. Jones,&nbsp;Andrea D. Smith","doi":"10.1111/obr.13839","DOIUrl":"10.1111/obr.13839","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Behavioral weight management interventions (BWMIs) are an evidence-based strategy for addressing childhood obesity. Targeting eating behavior traits (EBTs; individual tendencies determining food intake/occasions) could play a pivotal role in improving the effectiveness of these behavioral interventions. The present study describes a systematic review and meta-analysis of the impact of BWMIs on eating behavior traits in children with overweight or obesity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Seven databases were searched, and eligible studies included randomized controlled trials reporting EBT outcomes following BWMIs delivered to children with overweight or obesity (&lt;18 years of age). Random effects meta-analyses were conducted to compare EBT outcomes for intervention and control groups. Synthesis without meta-analysis (SWiM) was applied for EBTs where meta-analysis was not feasible.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The review identified eight trials characterizing the impact of BWMIs on 15 EBTs. Meta-analyses of data from three trials at intervention completion and post-intervention (average of 28 weeks [±8]) revealed positive short-term increases in dietary restraint (SMD random effect 0.42 [95% CI 0.13, 0.70]). However, these effects were not sustained at follow-up. Improvements in emotional eating, external eating, food responsiveness, and enjoyment of food were shown in studies which could not be pooled quantitatively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>BWMIs in children living with overweight/obesity are beneficial for the improvement of some EBTs at intervention completion including dietary restraint, emotional eating, external eating, food responsiveness, and enjoyment of food. However, this remains a relatively unexplored area and more research is needed to strengthen understanding of the multifaceted impact of child BWMIs on a comprehensive range of EBTs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13839","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142277688","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Higher fiber higher carbohydrate diets better than lower carbohydrate lower fiber diets for diabetes management: Rapid review with meta-analyses 高纤维、高碳水化合物饮食比低碳水化合物、低纤维饮食更有利于糖尿病的控制:快速回顾与荟萃分析。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-19 DOI: 10.1111/obr.13837
Andrew N. Reynolds, Jessica Lang, Amanda Brand, Jim Mann
{"title":"Higher fiber higher carbohydrate diets better than lower carbohydrate lower fiber diets for diabetes management: Rapid review with meta-analyses","authors":"Andrew N. Reynolds,&nbsp;Jessica Lang,&nbsp;Amanda Brand,&nbsp;Jim Mann","doi":"10.1111/obr.13837","DOIUrl":"10.1111/obr.13837","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Some dietary recommendations continue to recommend carbohydrate restriction as a cornerstone of dietary advice for people with diabetes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Purpose&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;We compared the cardiometabolic effects of diets higher in both fiber and carbohydrate with lower carbohydrate lower fiber diets in type 1 or type 2 diabetes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data sources&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;MEDLINE, Embase, and the Cochrane Database of Systematic Reviews up to June 24, 2024, with additional hand searching.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Study selection&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Randomized controlled trials in which both dietary fiber and carbohydrate amount had been modified were identified from source evidence syntheses on carbohydrate amount in people with diabetes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data extraction&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Two reviewers independently.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data synthesis&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Ten eligible trials including 499 participants with diabetes (98% with T2) were identified from the potentially eligible 828 trials included in existing evidence syntheses. Pooled findings indicate that higher fiber higher carbohydrate diets reduced HbA1c (mean difference [MD] −0.50% [95% confidence interval −0.99 to −0.02]), fasting insulin (MD −0.99 μIU/mL [−1.83 to −0.15]), total cholesterol (MD −0.16 mmol/L [−0.27 to −0.05]) and low-density lipoprotein cholesterol (MD −0.16 mmol/L (−0.31 to −0.01) when compared with lower carbohydrate lower fiber diets. Trials with larger differences in fiber and carbohydrate intakes between interventions reported greater reductions. Certainty of evidence for these outcomes was moderate or high, with most outcomes downgraded due to heterogeneity unexplained by any single variable.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Limitations&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Our predefined scope excluded trials with co-interventions such as energy restriction, which may have provided addition information.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Findings indicate the greater importance of promoting dietary fiber intakes, and the relative unimportance of carbohydrate amount in recommendations for people with diabetes.&lt;/p&gt;\u0000 ","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13837","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity 在使用增量素模拟药物治疗肥胖症期间尽量减少肌肉流失的策略。
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-19 DOI: 10.1111/obr.13841
Jeffrey I. Mechanick, W. Scott Butsch, Sandra M. Christensen, Osama Hamdy, Zhaoping Li, Carla M. Prado, Steven B. Heymsfield
{"title":"Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity","authors":"Jeffrey I. Mechanick,&nbsp;W. Scott Butsch,&nbsp;Sandra M. Christensen,&nbsp;Osama Hamdy,&nbsp;Zhaoping Li,&nbsp;Carla M. Prado,&nbsp;Steven B. Heymsfield","doi":"10.1111/obr.13841","DOIUrl":"10.1111/obr.13841","url":null,"abstract":"<p>The rapid and widespread clinical adoption of highly effective incretin-mimetic drugs (IMDs), particularly semaglutide and tirzepatide, for the treatment of obesity has outpaced the updating of clinical practice guidelines. Consequently, many patients may be at risk for adverse effects and uncertain long-term outcomes related to the use of these drugs. Of emerging concern is the loss of skeletal muscle mass and function that can accompany rapid substantial weight reduction; such losses can lead to reduced functional and metabolic health, weight cycling, compromised quality of life, and other adverse outcomes. Available evidence suggests that clinical trial participants receiving IMDs for the treatment of obesity lost 10% or more of their muscle mass during the 68- to 72-week interventions, approximately equivalent to 20 years of age-related muscle loss. The ability to maintain muscle mass during caloric restriction-induced weight reduction is influenced by two key factors: nutrition and physical exercise. Nutrition therapy should ensure adequate intake and absorption of high-quality protein and micronutrients, which may require the use of oral nutritional supplements. Additionally, concurrent physical activity, especially resistance training, has been shown to effectively minimize loss of muscle mass and function during weight reduction therapy. All patients receiving IMDs for obesity should participate in comprehensive treatment programs emphasizing adequate protein and micronutrient intakes, as well as resistance training, to preserve muscle mass and function, maximize the benefit of IMD therapy, and minimize potential risks.</p>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet 脂质和脂肪细胞参与肿瘤进展,重点是肥胖和饮食
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-17 DOI: 10.1111/obr.13833
Chiara Calabrese, Giacomo Miserocchi, Alessandro De Vita, Chiara Spadazzi, Claudia Cocchi, Silvia Vanni, Sofia Gabellone, Giovanni Martinelli, Nicoletta Ranallo, Alberto Bongiovanni, Chiara Liverani
{"title":"Lipids and adipocytes involvement in tumor progression with a focus on obesity and diet","authors":"Chiara Calabrese,&nbsp;Giacomo Miserocchi,&nbsp;Alessandro De Vita,&nbsp;Chiara Spadazzi,&nbsp;Claudia Cocchi,&nbsp;Silvia Vanni,&nbsp;Sofia Gabellone,&nbsp;Giovanni Martinelli,&nbsp;Nicoletta Ranallo,&nbsp;Alberto Bongiovanni,&nbsp;Chiara Liverani","doi":"10.1111/obr.13833","DOIUrl":"10.1111/obr.13833","url":null,"abstract":"<p>The adipose tissue is a complex organ that can play endocrine, metabolic, and immune regulatory roles in cancer. In particular, adipocytes provide metabolic substrates for cancer cell proliferation and produce signaling molecules that can stimulate cell adhesion, migration, invasion, angiogenesis, and inflammation. Cancer cells, in turn, can reprogram adipocytes towards a more inflammatory state, resulting in a vicious cycle that fuels tumor growth and evolution. These mechanisms are enhanced in obesity, which is associated with the risk of developing certain tumors. Diet, an exogenous source of lipids with pro- or anti-inflammatory functions, has also been connected to cancer risk. This review analyzes how adipocytes and lipids are involved in tumor development and progression, focusing on the relationship between obesity and cancer. In addition, we discuss how diets with varying lipid intakes can affect the disease outcomes. Finally, we introduce novel metabolism-targeted treatments and adipocyte-based therapies in oncology.</p>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"25 12","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/obr.13833","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of intermittent fasting and caloric restriction on inflammatory biomarkers in individuals with obesity/overweight: A systematic review and meta-analysis of randomized controlled trials 间歇性禁食和热量限制对肥胖/超重患者炎症生物标志物的影响:随机对照试验的系统回顾和荟萃分析
IF 8 2区 医学
Obesity Reviews Pub Date : 2024-09-17 DOI: 10.1111/obr.13838
Ahmad Bin Aamir, Roopa Kumari, Rabia Latif, Shakil Ahmad, Nazish Rafique, Ayad M. Salem, Lubna I. Alasoom, Ahmed Alsunni, Aseel S. Alabdulhadi, Subhash Chander
{"title":"Effects of intermittent fasting and caloric restriction on inflammatory biomarkers in individuals with obesity/overweight: A systematic review and meta-analysis of randomized controlled trials","authors":"Ahmad Bin Aamir,&nbsp;Roopa Kumari,&nbsp;Rabia Latif,&nbsp;Shakil Ahmad,&nbsp;Nazish Rafique,&nbsp;Ayad M. Salem,&nbsp;Lubna I. Alasoom,&nbsp;Ahmed Alsunni,&nbsp;Aseel S. Alabdulhadi,&nbsp;Subhash Chander","doi":"10.1111/obr.13838","DOIUrl":"10.1111/obr.13838","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Obesity is characterized by chronic low-grade inflammation. This study presents an updated systematic review and meta-analysis on the effect of caloric restriction (CR) and intermittent fasting (IF) on plasma inflammatory biomarkers (C-reactive protein [CRP], tumor necrosis factor [TNF]-alpha, and interleukin [IL]-6) in individuals with obesity/overweight compared with unrestricted or ad libitum feeding.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>PubMed, Web of Science, and SCOPUS databases were searched for randomized controlled trials (RCTs) reporting inflammatory biomarkers after at least 8 weeks of intervention. Standardized mean differences (SMDs) were calculated using a fixed effect model. Heterogeneity was determined using <i>I</i><sup>2</sup> statistics. Sensitivity analysis was conducted using the “leave-one-out” approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Relatively few RCTs have investigated the effect of IF on inflammatory biomarkers than with CR (6 vs. 15). Analysis of pooled data showed that CR was associated with a significant reduction in CRP with low heterogeneity (SMD −0.15 mg/L [95% CI −0.30 to −0.00], <i>p</i> = 0.04; <i>I</i><sup>2</sup> = 0%, <i>p</i> = 0.69) and IL-6 with high heterogeneity (SMD −0.31 pg/mL [95% CI −0.51 to −0.10], <i>p</i> = 0.004; <i>I</i><sup>2</sup> = 73%, <i>p</i> = 0.001). IF was associated with a significant decrease in TNF-alpha with moderate heterogeneity (SMD −0.32 pg/mL [95% CI −0.63 to −0.02], <i>p</i> = 0.04; <i>I</i><sup>2</sup> = 44%, <i>p</i> = 0.13). No associations were detected between IF and CRP or IL-6 and CR and TNF-alpha.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>CR may be more effective in reducing chronic low-grade inflammation than IF. However, there were some concerns regarding the included studies' randomization and allocation sequence concealment process.</p>\u0000 </section>\u0000 </div>","PeriodicalId":216,"journal":{"name":"Obesity Reviews","volume":"26 1","pages":""},"PeriodicalIF":8.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142249380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信